Cells change their metabolic profiles in response to underlying gene regulatory networks, but how can alterations in metabolism encode specific transcriptional instructions? Here, we show that forcing ...

Currently, moon blindness is treated mostly with steroids applied topically or injected into the eye during a flare-up in an ...

A 56-year-old man presented for 3 weeks of intermittent blurred vision and photophobia.His medical history included type 2 diabetes, hypertension, hyperlipidemia, chronic obstructive pulmonary disease ...

med.uni-heidelberg.de Purpose Previously we could show increased numbers and densities of dendritic-like cells (DLCs) in the subbasal nerve plexus of the central cornea in patients with herpetic ...

Researchers characterized pathogens associated with infectious uveitis using conventional diagnostics and metagenomic sequencing in intraocular fluid samples. Metagenomic RNA Sequencing offers an ...

In a new study, researchers identified a molecule produced by a particular type of brain cell that reversed the cognitive decline seen in both healthy aging and dementia. It provides a deeper ...

Now, researchers at Memorial Sloan Kettering Cancer Center (MSK) have a likely answer as to why that’s the case: Thetis cells. Moreover, the study, which was conducted in mouse models, points to a ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

GM and LG Energy Solution unveiled the “first-ever” lithium manganese-rich (LMR) prismatic EV battery cells. The new battery cells will be used in upcoming GM EV models, especially trucks and ...

Entamoeba histolytica has the unusual ability to kill human cells and then wear them as a disguise to escape the immune defenses. The research, the teams said, could pave the way for new ...

In an aging brain, cells that stop working yet refuse to die may play a role in dementia—making them key targets for future medicines. Senescent cells—also called zombie cells (background ...

While some therapies failed trials, others demonstrated promising results, including dazdotuftide (Tarsier Pharma), which reduced inflammation in patients with uveitis without raising IOP in a ...